On the draft Commission implementing decision authorising the placing on the market of products containing, consisting of or produced from genetically modified maize DP51291 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council
B-10-2025-0407
Committee on the Environment, Climate and Food Safety · Rapporteur: Martin Häusling, Biljana Borzan, Anja Hazekamp, Sirpa Pietikäinen
- Voted on · Adopted 433–166–9 · See the decision →
- Full procedure 2025/2807
Written by a language model from the full text only; every figure comes from the text. The paragraph links open the paragraph a statement rests on — check the text itself before relying on it.
Parliament objects to the Commission's draft decision authorising genetically modified maize DP51291, considering it exceeds implementing powers and is inconsistent with EU law.¶¶ It calls on the Commission to withdraw the draft decision, not authorise the maize due to risks to biodiversity, food safety and health, and to align standards with trading partners.¶¶¶ It also urges the Commission to honour commitments on hazardous chemicals and international obligations.¶¶
Key points
- The GM maize produces the IPD072Aa toxin against corn rootworm, the PAT protein for glufosinate tolerance, and the PMI protein as a marker.¶
- Glufosinate is classified as toxic for reproduction and its approval expired in 2018; the GM maize is tolerant to it.¶
- The genetic engineering process was complex, causing deletions and novel proteins, some with allergenicity potential.¶¶
- Field trials were limited to one season and did not reflect diverse conditions or climate change impacts.¶¶
- Glufosinate application in trials was limited, not reflecting real-world use; its risks to biodiversity and health are not assessed.¶¶¶
- Herbicide-tolerant crops lead to increased herbicide use and resistance, harming soil, water and biodiversity.¶¶¶
- IPD072Aa is a new protein with potential immune effects; interactions with herbicides and metabolites are not assessed.¶¶¶
- No data on environmental dissemination or effects on non-target organisms; gene flow to wild relatives is a concern.¶¶
- Monitoring requirements are insufficiently enforced, with no independent verification of data.¶
- Imports would disadvantage EU farmers who cannot cultivate the GM maize; the Commission should consider international obligations.¶¶
- The Commission continues to authorise GMOs despite lack of Member State support and Parliament's objections.¶¶
Who is affected
- Corteva Agriscience, the applicant, would be affected if the authorisation is withdrawn.¶
- EU farmers would face competitive disadvantage from imports of GM maize not permitted for cultivation in the Union.¶
- Consumers and the environment in the EU would be exposed to potential risks from the GM maize and associated herbicide use.¶¶